| For: | Al Awadhi S, Al Hassani A, El Ouali S, Alam MB, Azar C, Georgopoulos F, Jazzar AN, Khassouan AM, Koutoubi Z, Nathwani RA, Quraishi MN. Second United Arab Emirates consensus guidance on the diagnosis and management of inflammatory bowel disease. World J Gastroenterol 2025; 31(35): 109882 [PMID: 41024766 DOI: 10.3748/wjg.v31.i35.109882] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v31/i35/109882.htm |
| Number | Citing Articles |
| 1 |
Noorah Al Hosani, Maitha Al Hosani, Abdulla A. Aljanahi, Mohammed N. Quraishi. STRIDE-II treatment target achievement in inflammatory bowel disease: a cross-sectional study from a tertiary IBD centre in the United Arab Emirates. Saudi Journal of Gastroenterology 2026; doi: 10.4103/sjg.sjg_90_26
|
| 2 |
Ajay Gade, Alessandra Saraga, Alfonso Elosua, Antony Ishan, Tina Deyhim, Nathan David Vanshelboym Rothschild, Adam S. Cheifetz, Konstantinos Papamichael. Therapeutic drug monitoring for de-escalating anti-tumor necrosis factor therapy in patients with inflammatory bowel disease. Expert Review of Clinical Pharmacology 2026; 19(2) doi: 10.1080/17512433.2026.2630758
|